Effector mechanisms in murine allograft rejection: Comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations

Transplant International

Volumn 15, Issue 6, 2002, Pages 302-309

  Youssef, Abdel Rahman ^a   Otley, Carolyn ^a   Mathieson, Peter W ^a   Smith, Richard M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Allograft rejection; Cytokine; Cytotoxic T cell; Delayed type hypersensitivity; Effector mechanism

Indexed keywords

FAS LIGAND; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; MINOR HISTOCOMPATIBILITY ANTIGEN; NITRIC OXIDE SYNTHASE; PERFORIN; PROTEIN P40; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLOGENEIC RESTRICTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DONOR; EFFECTOR CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; HISTOPATHOLOGY; IMMUNOGENICITY; ISOGRAFT; MACROPHAGE; MALE; MINOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECIPIENT; SKIN GRAFT;

ANIMALS; CYTOKINES; GENE EXPRESSION PROFILING; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HYPERSENSITIVITY, DELAYED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MINOR HISTOCOMPATIBILITY ANTIGENS; MYOCARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; SKIN TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 0036933958     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2002.tb00169.x     Document Type: Article

References (52)

1. Ben-Ari Z, Dhillon AP, Moqbel R et al. (1996) Monoclonal antibodies against eosinophils in liver allograft rejection. Liver Transpl Surg 2:46-51
2. Billingham RE, Medawar PB (1951) The technique of free skin grafting in mammals. J Exp Biol 28:385
3. Bishop DK, Chan S, Li W, Ensley RD, Xu S, Eichwald EJ (1993) CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Transplantation 56:862-867
4. Borson ND, Strausbach MA, Kennedy RB, Oda RP, Landers JP, Wettstein PJ (1999) Temporal sequence of perforin. Fas ligand and tumor necrosis factor-a genes in rejecting skin allografts. Transplantation 67:672-680
5. Brent L (1997) A history of transplantation immunology. Academic Press
6. + T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 59:1155-1161
7. Chen Z (1991) A technique of cervical heterotopic heart transplantation in mice. Transplantation 52:1099-1101
8. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
9. Dallman MJ (1996) Molecular biology of the allograft response. Transplant Proc 28:2-6
10. Dallman MJ (1998) Polymerase chain reaction methods in immunology. Transplant Proc 30:2367-2369
11. Dallman MJ, Larsen CP, Morris PJ (1991) Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 174:493-196
12. -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J Immunol 156:4114-4119
13. Fahey T Jr, Turbeville T, McIntyre K (1995) Differential TNF secretion by wound fibroblasts compared to normal fibroblasts in response to LPS. J Surg Res 58:759-764
14. Feiken E, Romer J, Eriksen J, Lund LR (1995) Neutrophils express tumor necrosis factor-alpha during mouse skin wound healing. J Invest Dermatol 105:120-123
15. Franco A, Tilly DA, Gramaglia I et al. (2000) Epitope affinity for MHC class I determines helper requirement for CTL priming. Nat Immunol 1:145-150
16. Freedman LR, Cerottini J-C, Brunner K (1972) In vivo studies of the role of cytotoxic T cells in tumor allograft immunity. J Immunol 109:1371-1378
17. Golding H, Mizuochi T, Singer A (1985) Specificity, phenotype and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens. J Immunol 135:1610-1615
18. Guymer RH, Mandel TE (1994) A comparison of corneal, pancreas, and skin grafts in mice: a study of the determinants of tissue immunogenicity. Transplantation 57:1251-1262
19. + T cell in allograft rejection. J Immunol 139:4022-4026
20. Haywood GA, Tsao PS, Von der Leyen HE et al. (1996) Expression of inducible nitric oxide synthase in human heart failure. Circulation 93:1087-1094
21. Henkart P (1994) Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343-346
22. Howard JC, Butcher GW (1981) The mechanism of graft rejection and the concept of antigenic strength. Scand J Immunol 14:687-691
23. + cells in the rejection of multiple minor H-disparate skin grafts. Transplantation 47:909-910
24. Katz SM, Cramer DV, Kunz HW, Gill TJ III (1983) Effect of major histocompatibility complex genetic disparities on cardiac and skin graft rejection in the rat. Transplantation 36:463-464
25. + T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med 172:291-302
26. Kock A, Schwarz T, Kirnbauer R et al. (1990) Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609-1614
27. + cells are essential for allorejection. J Exp Med 184:2013-2018
28. Le Moine A, Surquin M, Demoor FX et al. (1999) IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice. J Immunol 163:3778-3784
29. Lewis NP, Tsao PS, Rickenbacher PR et al. (1996) Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 93:720-729
30. Lipman ML, Stevens AC, Strom TB (1994) Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol 152:5120-5127
31. Mandel TE, Dillon H, Koulmanda M (1995) The effect of a depleting antiCD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of mice. Transpl Immunol 3:265-272
32. + T cells. J Immunol 161:5236-5244
33. Mintz B, Silvers WK (1967) "Intrinsic" immunological tolerance in allophenic mice. Science 158:1484-1487
34. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165-190
35. Mottram PL, Han WR, Purcell LT, McKenzie IFC, Hancock WW (1995) Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-g in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 59:559-565
36. Nickerson P, Pacheco-Silva A, O'Connell PJ, Steurer W, Kelley VR, Strom TB (1993) Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction. Transplant Proc 25:984-985
37. O'Connell PJ, Pacheco-Silva A, Bastos M et al. (1991) Sequential analysis by polymerase chain reaction of mononuclear leukocyte activation-associated transcription in pancreatic islet cell allograft rejection. Transplant Proc 23:811-812
38. Peugh WN, Superina RA, Wood KJ, Morris PJ (1986) The role of H-2 and non-H-2 antigens and genes in the rejection of murine cardiac allografts. Immunogenetics 23:30-37
39. + cytotoxic T lymphocyte-mediated lysis. J Immunol 150:4303-4314
40. + T-helper and a T-killer cell. Nature 393:474-478
41. Rosenberg AS, Singer A (1988) Evidence that the effector mechanism of skin allograft rejection is antigen specific. Proc Nat Acad Sci USA 85:7739-7742
42. Rosenberg A, Singer A (1992) Cellular basis of skin allograft rejection: An in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 10:333-358
43. Saggi BH, Fisher RA, Bu D, Tawes JW, Riley R, Posner MP (1999) Intragraft cytokine expression and tolerance induction in rat renal allografts. Transplantation 67:206-210
44. Strehlau J, Pavlakis M, Lipman M, Maslinski W, Shapiro M, Strom TB (1996) The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation. Clin Nephrol 46:30-33
45. Sutton R, Gray DWR, McShane P, Dallman MJ, Morris PJ (1989) The specificity of rejection and the absence of susceptibility of pancreatic islet beta cells to nonspecific immune destruction in mixed strain islets grafted beneath the renal capsule in the rat. J Exp Med 170:751-762
46. Takeuchi T, Lowry RP, Konieczny B (1992) Heart allografts in murine systems. The differential activation of Th2like effector cells in peripheral tolerance. Transplantation 53:1281-1294
47. Ten RM, Gleich GJ, Holley KE, Perkins JD, Torres VE (1989) Eosinophil granule major basic protein in acute renal allograft rejection. Transplantation 47:959-963
48. Trinchieri G (1995) Interleukin 12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251-276
49. Ushio Y, Yamamoto N, Sanchez-Bueno A, Yoshida R (1996) Failure to reject an allografted tumor after elimination of macrophages in mice. Microbiol Immunol 40:489-498
50. Wang Y-C, Mayne A, Sell KW, Ahmed-Ansari A (1990) The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/II expression in donor tissue. Transplantation 50:313-324
51. + T cells can reject major histocompatibility complex class I-incompatible skin grafts. Eur J Immunol 29:156-167
52. Zhang Z, Zhu L, Quan D et al. (1996) Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 62:1267-1272